首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Implementation of a Microwave-assisted Tissue-processing System and an Automated Embedding System for Breast Needle Core Biopsy Samples: Morphology, Immunohistochemistry, and FISH Evaluation
【24h】

Implementation of a Microwave-assisted Tissue-processing System and an Automated Embedding System for Breast Needle Core Biopsy Samples: Morphology, Immunohistochemistry, and FISH Evaluation

机译:微波辅助组织处理系统和自动包埋系统用于乳腺针芯活检样品的实施:形态,免疫组织化学和FISH评估

获取原文
获取原文并翻译 | 示例
       

摘要

A platform composed of a microwave (MW)-assisted tissue-processing system and an automated embedding system has been recently introduced in pathology laboratories. Needle core biopsy (NCB) is an established, highly accurate method for diagnosing breast lesions and for providing important pathologic, predictive, and prognostic information such as biomarker expression in case of breast carcinoma. The aim of this study was to evaluate whether breast NCBs processed with the MW-assisted tissue-processing system and automatically embedded show good-quality histology preparations and whether they are suitable for the assessment of estrogen receptor (ER), progesterone receptor (PR), Ki-67, and HER2 in breast carcinoma. A series of 233 consecutive breast NCBs processed by both conventional and MW-assisted tissue-processing systems was included in this study. The histomorphologic and immunohistochemical quality, as well as the results of the evaluation of the biomarkers, were compared - the conventional processing method being the gold standard for comparison. The quality of hematoxylin-eosin and immunohistochemical tissue sections provided by the new system is comparable to that obtained after the conventional processing method. Moreover, in breast carcinomas, a perfect agreement between the paired tissues when evaluating ER and PR status (Cohen κ=1) and a very good agreement when evaluating Ki-67 (κ=0.91) and HER2 (κ=0.93) have been found. In conclusion, applying strict criteria in tissue-handling steps, breast NCB can be processed and automatically embedded with these platforms. The diagnosability and the evaluation of the main prognostic and predictive biomarkers have been proved to be reliable.
机译:由微波(MW)辅助组织处理系统和自动包埋系统组成的平台最近已在病理实验室中引入。针芯活检(NCB)是一种成熟的,高度准确的方法,用于诊断乳腺病变并提供重要的病理,预测和预后信息,例如在乳腺癌中表达生物标志物。这项研究的目的是评估用MW辅助组织处理系统处理并自动嵌入的乳腺NCB是否显示高质量的组织学准备,以及它们是否适合评估雌激素受体(ER),孕激素受体(PR) ,Ki-67和HER2在乳腺癌中的作用。这项研究包括了一系列由常规和兆瓦辅助组织处理系统处理过的233个连续的乳房NCB。比较了组织形态学和免疫组化质量以及生物标志物的评估结果-常规加工方法是进行比较的金标准。新系统提供的苏木精-曙红和免疫组织化学组织切片的质量与传统加工方法后的质量相当。此外,在乳腺癌中,发现评估ER和PR状态时配对组织之间的完美一致性(Cohenκ= 1)和评估Ki-67(κ= 0.91)和HER2(κ= 0.93)时的一致性非常好。 。总之,在组织处理步骤中应用严格的标准,可以处理乳房NCB并将其自动嵌入这些平台。主要的预后和预测性生物标志物的可诊断性和评估已被证明是可靠的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号